These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33734075)

  • 1. [Healing of severe morbus Crohn-related pyoderma gangrenosum after colectomy].
    Henneberg J; Heidenheim M; Munck LK
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parastomal pyoderma gangrenosum in inflammatory bowel disease.
    Tjandra JJ; Hughes LE
    Dis Colon Rectum; 1994 Sep; 37(9):938-42. PubMed ID: 8076495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peristomal pyoderma gangrenosum after colectomy for Crohn disease. Successful medical treatment].
    Goudet P; Pillon D; Bensa F; Collet E; Cougard P; Viard H
    Ann Chir; 1992; 46(6):525-9. PubMed ID: 1444154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pyoderma gangrenosum, a nonintestinal manifestation of Lesniowski-Crohn's disease in a 15 years old girl].
    Müller L; Bala G; Kuczyńska R; Czerwionka-Szaflarska M
    Med Wieku Rozwoj; 2006; 10(2):463-73. PubMed ID: 16825717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.
    Argüelles-Arias F; Castro-Laria L; Lobatón T; Aguas-Peris M; Rojas-Feria M; Barreiro-de Acosta M; Soto-Escribano P; Calvo-Moya M; Ginard-Vicens D; Chaparro-Sánchez M; Hernández-Durán M; Castro-Senosiain B; Fernández-Villaverde A; García-Sánchez V; Domínguez-Muñoz E; Caunedo-Álvarez A; Herrerías-Gutiérrez JM
    Dig Dis Sci; 2013 Oct; 58(10):2949-54. PubMed ID: 23828140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
    Carp JM; Onuma E; Das K; Gottlieb AB
    Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of SAPHO syndrome with pyoderma gangrenosum and inflammatory bowel disease masquerading as Behçet's disease.
    Yamasaki O; Iwatsuki K; Kaneko F
    Adv Exp Med Biol; 2003; 528():339-41. PubMed ID: 12918720
    [No Abstract]   [Full Text] [Related]  

  • 10. Peristomal cutaneous Crohn's disease by contiguity.
    Palomar Ávila C; Moreno Pimentel C; Masero Carretero JM; Coca López M
    Rev Esp Enferm Dig; 2023 Aug; 115(8):454-455. PubMed ID: 35791785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
    Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
    Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Certolizumab pegol - A new therapeutic option for refractory disseminated pyoderma gangrenosum associated with Crohn's disease.
    Hurabielle C; Schneider P; Baudry C; Bagot M; Allez M; Viguier M
    J Dermatolog Treat; 2016; 27(1):67-9. PubMed ID: 25909366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximab.
    Ljung T; Staun M; Grove O; Fausa O; Vatn MH; Hellström PM
    Scand J Gastroenterol; 2002 Sep; 37(9):1108-10. PubMed ID: 12374238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.
    Funayama Y; Kumagai E; Takahashi K; Fukushima K; Sasaki I
    Dis Colon Rectum; 2009 Feb; 52(2):311-4. PubMed ID: 19279428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beclometasone inhaler used to treat pyoderma gangrenosum.
    Chriba M; Skellett AM; Levell NJ
    Clin Exp Dermatol; 2010 Apr; 35(3):337-8. PubMed ID: 20500206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum.
    Triantafillidis JK; Cheracakis P; Sklavaina M; Apostolopoulou K
    Scand J Gastroenterol; 2002 Jul; 37(7):863-5. PubMed ID: 12190104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyoderma gangrenosum after colectomy in patients with inflammatory bowel disease.
    Siddiqui F; Liakos W; Toussi A; Downing L; Tran M; Nava J; Le ST; Maverakis E
    J Dtsch Dermatol Ges; 2021 Oct; 19(10):1508-1509. PubMed ID: 34363317
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peristomal pyoderma gangrenosum after rectal adenocarcinoma in the context of colonic and complex perianal Crohn's disease].
    Olmedo Martín RV; Amo Trillo V; López Ortega S; Jiménez Pérez M
    Gastroenterol Hepatol; 2016 May; 39(5):338-41. PubMed ID: 26096287
    [No Abstract]   [Full Text] [Related]  

  • 20. Ustekinumab in a patient with pyoderma gangrenosum and refractory Crohn's disease.
    García Cámara P; Zubiri Ara ML; García López S
    Med Clin (Barc); 2019 Oct; 153(8):e35-e36. PubMed ID: 30795905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.